Breaking News! HPV Vaccine Officially Included in National Immunization Program

Recently, with the approval of the State Council, the National Administration of Disease Prevention and Control (NADC), National Health Commission (NHC), Ministry of Education (MOE), Ministry of Industry and Information Technology (MIIT), Ministry of Finance (MOF), National Medical Products Administration (NMPA), and the Office of the National Working Committee on Women and Children jointly issued the "Notice on Matters Concerning the Inclusion of Human Papillomavirus (HPV) Vaccine in the National Immunization Program" (Guo Ji Kong Wei Mian Fa〔2025〕No. 16). It is decided that starting from November 10, 2025, the HPV vaccine will be officially included in the national immunization program, providing free vaccination for eligible girls of appropriate age.

According to the notice, from November 10, 2025 onwards, local authorities will offer free vaccination of two doses of bivalent HPV vaccine to girls born on or after November 10, 2011, who have reached the age of 13. The interval between the two doses is 6 months. This initiative aims to implement the "Vaccine Administration Law of the People's Republic of China" and the "Accelerated Action Plan for Eliminating Cervical Cancer (2023—2030)", reduce the disease burden caused by HPV infection such as cervical cancer, and protect the health of the general public.

The notice requires local governments and relevant departments to attach great importance to this work, strengthen organizational leadership and inter-departmental cooperation, and ensure the safe and orderly progress of vaccination. Disease prevention and control departments at all levels shall, in conjunction with education and health departments, accurately identify the target population, formulate specific implementation plans, and carry out personnel training and information system upgrades in advance. The MIIT and NMPA shall ensure vaccine production, supply, and quality safety, and the Chinese Center for Disease Control and Prevention (China CDC) will uniformly organize centralized bidding and procurement of vaccines.

In terms of publicity and mobilization, local areas will extensively carry out science popularization and education to enhance the vaccination willingness of the target population and their guardians. During the vaccination implementation, reasonable vaccination sites will be set up, and safety measures such as health inquiry, post-vaccination observation, and monitoring and handling of suspected adverse reactions will be strictly implemented to ensure standardized vaccination procedures and high-quality services.

In addition, the notice emphasizes strengthening the whole-process management of vaccines, improving the inter-departmental cooperation and funding guarantee mechanism, and ensuring the smooth advancement of the HPV vaccine immunization program.

The implementation of this policy marks an important step for China in eliminating cervical cancer and safeguarding women's health.